Username: Password:
Blog Articles Tagged With   "phase"
Sorted by: Date Source Subscribe On Your Mobile   Subscribe

BioSante: Key Support Is Back
In SeekingAlpha ETFs - Posted 5 days ago
Earlier this week BioSante Pharma (BPAX) reported 3Q08 results which included a net loss of $6.6M or ($0.24) per share and a loss of $16.3M or ($0.60)...
Tags: pharma phase
Human Genome Sciences Awaiting Crucial Albuferon Data
In SeekingAlpha Biotech Stocks - Posted 5 days ago
Recent headlines that Susquehanna analysts have downgraded their rating on Human Genome Sciences (HGSI) from positive to neutral , whilst n...
Tags: biotech phase
Human Genome Sciences Awaiting Crucial Albuferon Data
In SeekingAlpha ETFs - Posted 5 days ago
Recent headlines that Susquehanna analysts have downgraded their rating on Human Genome Sciences (HGSI) from positive to neutral , whilst n...
Tags: biotech data lows phase trading
The next phase begins in Minnesota (388054)
In A Canadian Econoview - Posted 1 week ago
THE NEXT PHASE BEGINS IN MINNESOTA.... With the razor-thin margin in the Senate race in Minnesota, the first phase in the Republican strategy was to a...
Tags: phase
Treasury Enters Its Lame-Duck Phase
In SeekingAlpha ETFs - Posted 1 week ago
A welcome sign of independent intelligent life at the NYT business section comes this morning, with Edmund Andrews' piece on Frannie's latest loan-mod...
Tags: phase
Chesapeake Energy Inks Marcellus Deal
In SeekingAlpha ETFs - Posted 1 week ago
The Money: $3.375 billion: $1.25 billion cash upfront; $2.125 billion in drilling costs over 2009-2012. The Position: Chesapeake Energy (CHK)...
Tags: drilling gas oil phase
ArQule Joins Forces with Daiichi Sankyo to Fight Cancer
In SeekingAlpha ETFs - Posted 1 week ago
ArQule and Daiichi Sankyo announced that they have entered into two agreements that form the basis of a strategic relationship for the development an...
Tags: data phase
ArQule Joins Forces with Daiichi Sankyo to Fight Cancer
In SeekingAlpha Biotech Stocks - Posted 1 week ago
ArQule and Daiichi Sankyo announced that they have entered into two agreements that form the basis of a strategic relationship for the development an...
Tags: phase
CB-1 Obesity Drugs: Farewell to the Whole Lot
In In the Pipeline - Posted 1 week ago
The painful saga of Acomplia (rimonabant) has finally come to an end. Sanofi-Aventis has announced that they're completely giving up on the drug. Ther...
Tags: phase
Acute Phase of Liquidity Crisis Has Passed; Bear Market Bottom Around the Corner?
In SeekingAlpha ETFs - Posted 2 weeks ago
Stock markets enjoyed a well-deserved relief rally last week, repairing some of the damage sustained in the free-fall that began in late September. In...
Tags: bear market markets phase
1
...

Featured Investment Blogs

24/7 Wall St.
Insightful Analysis and Commentary for U.S. and Global Equity Investors...
Environmental Economics
Economists on Environmental and Natural Resources: News, Opinion, and Analysis...
Paul Kedrosky's Infectious Greed
Musing about technology, finance, venture capital, & the money culture with Paul Kedrosky...
Jeff Matthews Is Not Making This Up
The World of Wall Street in all its glory, and anything else that strikes our fancy. Informed observations about comp...
Stock Market Beat
Our beat is the stock market. Our job is to beat it....
TechCrunch
TechCrunch profiles the companies, products and events that are defining and transforming the new web. TechCrunch is ...
Trader Mike
Stock market commentary & trading ideas. Stock market weblog (blog), swing trading, day trading, stock picks, techni...